Myo-inositol
Sugar alcohol studied in PCOS, with limited and inconclusive evidence and no clear advantage over metformin for reproductive outcomes.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- PCOS: 2 g twice daily, often in a 40:1 myo:D-chiro-inositol ratio
- Time to effect
- Not established
- Safety
- Has documented cautions
Evidence ratings summarise published research on Myo-inositol in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Myo-inositol
Interactions
Taking any medication?
Check Myo-inositol against it.
Why
Myo-inositol is a sugar alcohol that functions as a second messenger in insulin and FSH signalling. Trials in polycystic ovary syndrome (PCOS) report some metabolic benefit, but a 2024 meta-analysis (30 trials, n=2,230) called the evidence limited and inconclusive, with likely no difference from metformin for reproductive outcomes and metformin possibly better for waist-hip ratio and hirsutism. A 2025 JAMA RCT (n=464) found no reduction in pregnancy complications in PCOS. The 40:1 myo-inositol to D-chiro-inositol ratio (physiological ratio) is the most-studied formulation.
How it works
Component of inositol phosphoglycan second messengers that mediate insulin action at the post-receptor level. In ovarian theca cells, supports FSH signalling and oestrogen synthesis. In skeletal muscle, supports GLUT4 translocation. Restores the disrupted myo:D-chiro inositol balance documented in PCOS.
Expected onset · Not established; trial durations vary
How to take
Dosage
PCOS: 2 g twice daily (4 g/day total), often in a 40:1 myo:D-chiro-inositol ratio. Trials run 3–6 months.
Timing
Twice daily with food
On the label
'Myo-inositol' with stated milligrams, or '40:1 myo-inositol : D-chiro-inositol' for the physiological-ratio formulation. Avoid pure D-chiro-inositol products (different effect, not equivalent).
Studied in
Women with PCOS who want to discuss a nutrient option with their clinician; evidence for fertility outcomes is inconclusive.
Safety
Evidence
Fitz 2024 J Clin Endocrinol Metab meta-analysis (30 trials, n=2,230): evidence for inositol in polycystic ovary syndrome was limited and inconclusive, with some metabolic benefit. Metformin may have improved waist-hip ratio and hirsutism more, with likely no difference in reproductive outcomes. van der Wel 2025 JAMA RCT (n=464) found no reduction in pregnancy complications in pregnant women with PCOS.
GRADE certainty: Low — reported by Cochrane 2018 (low to very low quality evidence for reproductive outcomes)
- Fitz V et al., Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines, J Clin Endocrinol Metab 2024
- Showell MG et al., Inositol for subfertile women with polycystic ovary syndrome, Cochrane Database Syst Rev 2018
- Moslehi N et al., Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials, Nutr Rev 2023
- van der Wel AWT et al., Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial, JAMA 2025
Questions people ask
Does Myo-inositol work?
Fitz 2024 J Clin Endocrinol Metab meta-analysis (30 trials, n=2,230): evidence for inositol in polycystic ovary syndrome was limited and inconclusive, with some metabolic benefit. Metformin may have improved waist-hip ratio and hirsutism more, with likely no difference in reproductive outcomes. van der Wel 2025 JAMA RCT (n=464) found no reduction in pregnancy complications in pregnant women with PCOS. Certainty of the evidence: Low, reported by Cochrane 2018 (low to very low quality evidence for reproductive outcomes).
How is Myo-inositol taken?
PCOS: 2 g twice daily (4 g/day total), often in a 40:1 myo:D-chiro-inositol ratio. Trials run 3–6 months. Timing: Twice daily with food. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Mild GI upset (nausea, flatulence) has been reported at high doses. Pregnancy: small RCTs in gestational diabetes prevention; otherwise data limited. Coordinate with the prescribing clinician. Interaction data are limited. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: Fitz V et al., Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines, J Clin Endocrinol Metab 2024; Showell MG et al., Inositol for subfertile women with polycystic ovary syndrome, Cochrane Database Syst Rev 2018; Moslehi N et al., Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials, Nutr Rev 2023; van der Wel AWT et al., Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial, JAMA 2025.
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.